DPP4 and diabetes mellitus: DPP-4i are a new class of anti-diabetes drugs that prevent the degradation of glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 by inhibiting dipeptidyl peptidase-IV (DPP-4) (18).